BOULDER, Colo., Sept. 2, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. 



    Event:     Wells Fargo Securities Healthcare Conference

    Presenter: Ron Squarer, Chief Executive Officer

    Date:      Thursday, September 10, 2015

    Time:      10:20 a.m. Eastern Time

    Webcast:   www.arraybiopharma.com

http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.



    CONTACT:                       Tricia Haugeto

                                   Array BioPharma Inc.

                                   303-386-1193

                                   thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-wells-fargo-securities-healthcare-conference-300137239.html

SOURCE Array BioPharma Inc.